Related Experiment Video
Updated: Sep 30, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Response of preschool children with asthma symptoms to fluticasone propionate
R J Roorda1, G Mezei, H Bisgaard
1Department of Pediatrics, Isala Klinieken, De Weezenlanden Hospital, Zwolle, The Netherlands.
Insights
Preschool children with frequent asthma symptoms or a family history of asthma benefit most from inhaled fluticasone propionate. This finding aids in predicting treatment success for young children with recurrent asthma symptoms.
Area of Science:
- Pediatric Pulmonology
- Allergy and Immunology
Background:
- Diagnosis and treatment of asthma in preschool children present significant challenges.
- Identifying subgroups that respond to therapy is crucial for effective management.
Purpose of the Study:
- To identify preschool children (12-47 months) with recurrent asthma symptoms most likely to respond to inhaled fluticasone propionate (200 microg/d).
Main Methods:
- Analysis of pooled data from two 12-week multicenter studies.
- Subgroup analysis based on symptom frequency and family history of asthma.
Main Results:
- Children with frequent symptoms showed a significantly greater improvement in symptom-free days with fluticasone propionate compared to placebo (45% vs 25%).
- Children with a family history of asthma also demonstrated significantly more symptom-free days and a higher proportion of exacerbation-free periods with fluticasone propionate.
- No significant treatment effect was observed in children with less frequent symptoms or no family history of asthma.
Conclusions:
- Frequent symptoms and a family history of asthma are key indicators for predicting a positive response to inhaled fluticasone propionate in preschool children.
- These results can guide personalized treatment strategies for managing recurrent asthma symptoms in this age group.
Background:
Many uncertainties remain in the diagnosis and treatment of preschool children with asthma symptoms.
Objective:
We sought to determine the subgroups of preschool children (aged 12-47 months) with recurrent asthma symptoms most likely to respond to inhaled fluticasone propionate (200 microg/d).
Methods:
Subgroups of pooled data from 2 similar 12-week multicenter studies were analyzed.
Results:
Children with frequent symptoms (symptoms on > or =3 days per week and a total of > or =75% days with symptoms during the 4-week run-in period; n = 169) showed a significantly greater increase in days without symptoms after fluticasone propionate treatment (0% to 45%) compared with after placebo treatment (0% to 25%, P =.005). Children with a family history of asthma (n = 213) also had a significantly greater increase in days without symptoms after fluticasone propionate (11% to 54%) compared with after placebo (7% to 35%, P =.002) and a significantly higher proportion of exacerbation-free patients (61% to 76%, P =.02). Children with less frequent symptoms, no family history of asthma, or both showed no significant treatment effect. There seemed to be no association between response to fluticasone propionate and history of rhinitis or eczema or the number of previous exacerbations.
Conclusions:
Children with frequent symptoms, a family history of asthma, or both showed the greatest response to fluticasone propionate treatment. These findings may help to predict treatment outcome and guide the management of preschool children with recurrent asthma symptoms.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma III: Clinical Manifestations

